Shringyadi Churna in classical Ayurveda

What it is

Shringyadi Churna is a classical Ayurvedic powder (churna) used for kasa (cough): but there is no single fixed recipe. A comparative review of classical sources documents different versions across the Sharangadhara Samhita, Yoga Ratnakara, Bhaishajya Ratnavali, Vrinda Madhava, Gada Nigraha and Chakradatta, so the name covers a family of related formulas rather than one composition (World J Pharm Res formulation comparison).

Two well-documented versions:

• Chakradatta version: karkatashringi (Pistacia integerrima), shunthi (Zingiber officinale, dried ginger), pippali (Piper longum), musta (Cyperus rotundus), pushkaramula (Inula racemosa), shati (Hedychium spicatum) and maricha (Piper nigrum), with an equal quantity of sharkara (sugar): the version analyzed in a 2020 review paper (Int J AYUSH & Allied Health).
• Sharangadhara version: karkatashringi with ativisha (Aconitum heterophyllum), pippali, shunthi and maricha, per the comparative formulation table (WJPR).

A 2022 pediatric trial used yet another three-ingredient version: karkatashringi, musta and ativisha (IAMJ 2022). Because the recipe varies, always check which version a product follows: study results for one version do not transfer to another.

The lead ingredient, karkatashringi (also called shringi), is the gall of Pistacia integerrima: a horn-shaped gall formed on the tree, used in Ayurveda for respiratory complaints (IJAHM).

Classical properties

• Taste (rasa): astringent (Kashaya), bitter (Tikta)
• Qualities (guna): light (Laghu)
• Potency (virya): warming (Ushna)
• After digestion (vipaka): pungent (Katu)
• Doshas: traditionally said to settle Vata and Kapha; may increase Pitta

Traditional use

These are traditional claims, not clinical proof.

Across the classical texts, Shringyadi Churna is described for the chest and kapha: kasa (cough), shwasa (breathing difficulty/asthma-like conditions) and related kapha respiratory disorders (WJPR). The 2020 review paper notes the Chakradatta version's traditional indications include cough, asthma and hiccup (hikka) (IJAHM). Traditional indication is not evidence of efficacy.

What research has looked at

Childhood cough (single-arm trial)

A 2022 single-group clinical study (Verma Neeharika et al., Int Ayurvedic Med J) enrolled 50 children with kaphaja kasa (phlegmy cough); 42 completed the study. The children received Shringyadi Churna (the karkatashringi–musta–ativisha version) with honey (madhu), with age-based dosing (Young's rule), for 20 days. The paper reports statistically significant improvements (p<0.001): e.g., cough severity 75.80%, phlegm expectoration 87.57%, sleep disturbance 88.88%: and the trial was registered as CTRI/2021/08/035375 (IAMJ 2022).

This was a single-group study with no control arm and notable dropout (8 of 50), so natural recovery and placebo effects cannot be ruled out: and the version tested is not the Chakradatta seven-herb recipe.

Bronchial asthma (combination study)

A study published in the Int J Ayurveda & Pharma Research gave 20 patients with tamaka shwasa (bronchial asthma) Shringyadi Churna together with Guduchyadi Kwatha for four weeks, reporting 80% marked improvement and 15% complete remission, with peak expiratory flow rate (PEFR) improving 34.83% (p<0.001) and SpO2 improving (IJAPR). Because two formulations were given together to a small uncontrolled group, the improvement cannot be attributed to Shringyadi Churna specifically.

What the evidence does not support

No randomized controlled trial of Shringyadi Churna, for cough, asthma, or anything else, was identified. Two small uncontrolled studies, one using a combination therapy, are weak evidence. Traditional use for cough and breathing difficulty is not clinical proof.

Safety notes

• Recipe matters for safety: some classical versions contain ativisha (Aconitum heterophyllum): a species in the Aconitum genus, which also contains notoriously poisonous aconites. Classical texts distinguish ativisha from the toxic species, but correct botanical identification and proper processing are essential (WJPR). Never use a version containing ativisha without a qualified practitioner, and never from an unverified source.
• The pediatric study dosed children under medical supervision with age-based (Young's rule) dosing: do not extrapolate adult doses to children at home (IAMJ 2022).
• Beyond the two small studies, systematic safety data is limited: pregnancy, breastfeeding, drug interactions and long-term use have not been studied. Safety data is limited: talk to a clinician.
• Persistent cough or breathing difficulty needs medical evaluation, especially in children and in anyone with asthma, rather than self-treatment with an herbal powder (IJAPR).

FAQs

What is Shringyadi Churna?

It is a classical Ayurvedic herbal powder for cough (kasa), led by karkatashringi: the gall of Pistacia integerrima. There is no single recipe: the Chakradatta version combines seven herbs with sugar, while other classical versions use karkatashringi with ativisha and pippali, and a pediatric trial used a three-herb version (IJAHM; WJPR).

Which recipe should I look for?

It depends on the source text your practitioner follows: but the key point is consistency: the Chakradatta seven-herb-plus-sugar version and the Sharangadhara karkatashringi–ativisha–pippali version are different medicines sharing a name (WJPR). Check the product label's ingredient list, and note that trial results for one version do not apply to another.

Does it work for cough in children?

One single-group study of 50 children (42 completed) with phlegmy cough reported significant symptom improvements after 20 days of a karkatashringi–musta–ativisha version with honey (IAMJ 2022). With no control group, this is weak evidence: and children were dosed under medical supervision, so do not replicate this at home.

Does it help asthma?

A 20-patient study of Shringyadi Churna combined with Guduchyadi Kwatha reported improved breathing measures over four weeks: but with two medicines given together and no control group, the effect cannot be credited to Shringyadi Churna (IJAPR). Asthma needs proper medical management; do not self-treat breathing difficulty.

Is ativisha (Aconitum heterophyllum) dangerous?

Ativisha belongs to the Aconitum genus, which includes highly poisonous species: though classical Ayurveda distinguishes ativisha from the toxic aconites (WJPR). Correct identification and processing are critical, so ativisha-containing versions should only be used under qualified practitioner supervision and from verified sources.

What dose was used in studies?

Swastik does not suggest amounts. The right amount depends on the person, the preparation and the product, so check with a qualified Ayurvedic practitioner or your doctor before taking any herb.

Sources

• Review of Shringyadi Churna (Chakradatta composition: karkatashringi, shunthi, pippali, musta, pushkaramula, shati, maricha + equal sharkara) — Int J AYUSH & Allied Health. 2020;10(3) — new.interscience.org.uk
• Comparative table of Shringyadi Churna versions across Sharangadhara Samhita, Yoga Ratnakara, Bhaishajya Ratnavali, Vrinda Madhava, Gada Nigraha and Chakradatta — World J Pharm Res. 2019 — wjpr.s3.ap-south-1.amazonaws.com
• Verma Neeharika et al. "A clinical study to evaluate the efficacy of Shringyadi Churna in the management of Kaphaja Kasa in children" — Int Ayurvedic Med J. 2022 (single-group, n=50/42 completed, karkatashringi–musta–ativisha with honey, Young's-rule dosing x 20 days; CTRI/2021/08/035375) — sup1gtd7m3wgv2qummrlhbqfg8yqoxrn.vcaahomes.top
• "Clinical evaluation of Shringyadi Churna and Guduchyadi Kwatha in Tamaka Shwasa" — Int J Ayurveda & Pharma Research (n=20, combination therapy x 4 weeks; PEFR +34.83%, p<0.001) — ijapr.in

Disclaimer

This article is for educational purposes only and is not medical advice. Herbal products can interact with medications and are not suitable for everyone. Talk to a qualified healthcare practitioner before use — especially if you are pregnant, breastfeeding, managing a medical condition, or taking prescription medicines.